Sep 27

CT 01 - Clinical Trials Session

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma

02:10pm - 02:20pm ET

Grand Ballroom

Presenter(s)

Leslie Ballas, MD, FASTRO - Cedars Sinai, Los Angeles, CA